Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AZN

Astrazeneca plc ADR

Last Close
Dec 01 • 04:00PM ET
64.79
Dollar change
+0.20
Percentage change
0.31 		%
Scroll to Statements
IndexNDX P/E34.26 EPS (ttm)1.89 Insider Own0.04% Shs Outstand3.10B Perf Week0.45%
Market Cap200.84B Forward P/E15.52 EPS next Y4.17 Insider Trans0.00% Shs Float3.10B Perf Month1.58%
Income5.90B PEG2.66 EPS next Q0.76 Inst Own16.17% Short Float / Ratio0.26% / 1.48 Perf Quarter-4.92%
Sales44.99B P/S4.46 EPS this Y9.82% Inst Trans-2.09% Short Interest8.10M Perf Half Y-10.75%
Book/sh12.00 P/B5.40 EPS next Y14.12% ROA6.20% Target Price82.52 Perf Year-4.68%
Cash/sh1.65 P/C39.26 EPS next 5Y12.90% ROE16.30% 52W Range61.73 - 76.56 Perf YTD-4.44%
Dividend1.52 P/FCF21.37 EPS past 5Y-2.17% ROI9.80% 52W High-15.37% Beta0.50
Dividend %2.34% Quick Ratio0.60 Sales past 5Y15.24% Gross Margin71.08% 52W Low4.96% ATR1.07
Employees83500 Current Ratio0.79 Sales Q/Q4.64% Oper. Margin16.34% RSI (14)53.14 Volatility1.10% 1.21%
OptionableYes Debt/Eq0.77 EPS Q/Q-16.27% Profit Margin13.10% Rel Volume0.66 Prev Close64.59
ShortableYes LT Debt/Eq0.62 EarningsNov 09 BMO Payout133.71% Avg Volume5.46M Price64.79
Recom1.28 SMA201.44% SMA50-0.71% SMA200-6.00% Volume3,616,175 Change0.31%
Date Action Analyst Rating Change Price Target Change
Sep-25-23Upgrade Jefferies Hold → Buy $66.50 → $80
Jul-14-23Initiated HSBC Securities Buy
Jul-12-23Upgrade UBS Neutral → Buy
Jul-05-23Downgrade Deutsche Bank Buy → Hold
Apr-11-23Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-05-23Initiated BMO Capital Markets Outperform $82
Sep-15-22Downgrade Credit Suisse Outperform → Neutral
Sep-07-22Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-29-22Upgrade Argus Hold → Buy $75
Jun-14-22Downgrade UBS Buy → Neutral
Show Previous Ratings
Dec-03-23 01:27AM
AstraZeneca, AI biologics firm Absci tie up on cancer drug
(Reuters)
01:22AM
UPDATE 2-AstraZeneca, AI biologics firm Absci tie up on cancer drug
(Reuters)
12:21AM
AstraZeneca ties up with AI biologics company to develop cancer drug - FT
(Reuters)
12:00AM
AstraZeneca ties up with AI biologics company to develop cancer drug
(Financial Times)
Dec-01-23 01:00PM
Directors Deals: Strategy refresh spurs Unilever directors
(Financial Times)
11:27AM Loading…
11:27AM
AstraZeneca (AZN) to Discontinue Two Studies on Lokelma
(Zacks)
Nov-30-23 11:04AM
UPDATE 1-Turkey launches investigation into 19 pharma companies
(Reuters)
08:00AM
Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO Technology
(PR Newswire)
Nov-29-23 04:57PM
17 Best European Countries to Move to from the USA
(Insider Monkey)
07:00AM
AstraZeneca advances scientific leadership in hematology at ASH 2023
(Business Wire)
Nov-28-23 05:59PM
15 Hardest Countries to Get Citizenship in Europe
(Insider Monkey)
10:25AM
UPDATE 2-White House urges RSV immunization makers to meet demand
(Reuters)
04:30AM
30 Countries with the Highest Quality of Life Heading into 2024
(Insider Monkey)
Nov-27-23 01:37PM
Tesla sues Sweden in bid to avoid hit from strikes
(The Telegraph)
05:48AM
AstraZeneca pays $24M to join race for next big KRAS opportunity, bagging Chinese rival to Mirati asset
(FierceBiotech.com)
03:11PM Loading…
Nov-26-23 03:11PM
12 Best Diabetes Stocks To Buy Now
(Insider Monkey)
06:51AM
15 Best Drug Stocks To Invest In
(Insider Monkey)
Nov-24-23 09:00AM
Investors Heavily Search AstraZeneca PLC (AZN): Here is What You Need to Know
(Zacks)
Nov-22-23 08:15AM
Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant
(Motley Fool)
08:10AM
AstraZeneca fights accusations its Covid-19 jab was defective
(Financial Times)
05:21AM
3 No-Brainer Stocks to Buy With $1,000 Right Now
(Motley Fool)
Nov-21-23 09:40AM
Here's Why Astrazeneca (AZN) is a Strong Value Stock
(Zacks)
Nov-20-23 08:27AM
AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes
(Business Wire)
07:48AM
12 European Countries with the Best Quality of Life
(Insider Monkey)
06:52AM
20 Most Valuable Healthcare Companies in the World
(Insider Monkey)
05:07AM
AstraZeneca creates digital health unit, with big-name partnerships already in place
(BioPharma Dive)
Nov-17-23 09:53AM
AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don't Rush to Buy the Stock
(Motley Fool)
08:06AM
AstraZeneca's (AZN) Capivasertib Gets FDA Nod for Breast Cancer
(Zacks)
07:00AM
TRUQAP (capivasertib) plus fulvestrant approved in the US for patients with advanced HR-positive breast cancer
(Business Wire)
Nov-16-23 05:26PM
UPDATE 2-US FDA approves AstraZeneca's breast cancer drug combination
(Reuters)
05:17PM Loading…
05:17PM
US FDA approves AstraZeneca's breast cancer drug combination
(Reuters)
02:20PM
CORRECTED-UPDATE 2-CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug
(Reuters)
02:10PM
CORRECTED-CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug
(Reuters)
10:43AM
AstraZeneca's Koselugo not a 'meaningful barrier' to SpringWorks' rare disease offering, executives say
(FierceBiotech.com)
Nov-15-23 10:10AM
AstraZeneca's (AZN) Imfinzi Early-Stage Lung Cancer Study Fails
(Zacks)
02:30AM
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
(GlobeNewswire)
Nov-14-23 01:30AM
AstraZeneca Targets New Pill as Cheaper Option for Losing a Bit of Weight
(Barrons.com)
Nov-13-23 06:03PM
11 Best European Stocks To Buy Now
(Insider Monkey)
09:00AM
Here is What to Know Beyond Why AstraZeneca PLC (AZN) is a Trending Stock
(Zacks)
Nov-10-23 02:51PM
AstraZeneca PLC (NASDAQ:AZN) Q3 2023 Earnings Call Transcript
(Insider Monkey)
02:18PM
AstraZeneca prioritizes US for RSV drug amid surge in cases
(Reuters)
11:38AM
AstraZeneca's long-term GLP-1 play is weight management, not obesity, CEO says
(FierceBiotech.com)
08:35AM
Weight-loss drug maker to spend £4.9bn on new facilities amid surging demand
(The Telegraph)
08:35AM
Wegovy maker to spend £4.9bn on new facilities amid obesity drug race
(The Telegraph)
08:11AM
AstraZeneca (AZN) Buys Global Rights to Oral Obesity Candidate
(Zacks)
08:05AM
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
(Zacks)
Nov-09-23 07:37PM
PRESS DIGEST-British Business - Nov. 10
(Reuters)
06:00PM
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
(Motley Fool)
05:10PM
Medicare drug price negotiations: AstraZeneca CEO's take
(Yahoo Finance Video)
05:02PM
AstraZeneca Is Making A $2 Billion Bet To Rival Lilly, Novo In Obesity Drugs
(Investor's Business Daily)
01:56PM
The battle for weight loss drug dominance is heating up. Here's why.
(Yahoo Finance)
01:25PM
Petrol garages under fire over rising margins at the pump
(The Telegraph)
01:16PM
Analyst Report: AstraZeneca PLC
(Morningstar Research)
01:01PM
AstraZeneca bets on weight-loss pill to compete with wave of new miracle jabs
(The Telegraph)
12:39PM
AstraZeneca enters weight-loss market with oral GLP-1 drug
(Yahoo Finance Video)
12:01PM
AstraZeneca Strikes a Deal for an Experimental Weight-Loss Drug and Boosts Its Guidance
(Investopedia)
11:09AM
AstraZeneca CFO: Obesity Market Has a Lot of Potential
(Bloomberg)
10:57AM
AstraZeneca Is Getting Into the Weight-Loss Drug Game. The Stock Needs a Boost.
(Barrons.com)
09:30AM
Astrazeneca (AZN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
(Zacks)
07:00AM
IMFINZI® (durvalumab) plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolization in EMERALD-1 Phase III trial
(Business Wire)
05:52AM
Astrazeneca: Q3 Earnings Snapshot
(Associated Press Finance)
05:38AM
AstraZeneca signs deal for oral obesity drug and lifts profit outlook
(Financial Times)
04:42AM
UPDATE 2-European shares hit 3-week high on earnings boost
(Reuters)
04:20AM
AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug
(FierceBiotech.com)
03:51AM
AstraZeneca to develop new weight-loss drug after striking £1.6bn deal
(The Telegraph)
02:49AM
UPDATE 1-China health sector sees better sentiment from anti-graft drive - execs
(Reuters)
02:39AM
UPDATE 3-AstraZeneca raises stakes in obesity drug race with Eccogene deal
(Reuters)
02:35AM
AstraZeneca Raises Core EPS Guidance Despite Profit Miss
(The Wall Street Journal)
02:05AM
AstraZeneca ups profit outlook and boosts anti-obesity pipeline
(Reuters)
01:52AM
China health sector sees better sentiment from anti-graft drive - execs
(Reuters)
Nov-08-23 01:27PM
Cellectis S.A. (NASDAQ:CLLS) Q3 2023 Earnings Call Transcript
(Insider Monkey)
10:35AM
AstraZeneca reports, Li Auto earnings, Tapestry: 3 things to watch
(Investing.com)
07:00AM
AstraZeneca to leverage its global industrial-scale manufacturing and digital capabilities to boost US renewable natural gas productivity
(Business Wire)
Nov-07-23 11:29AM
U.S. FTC disputes Orange Book listing for some drug patents
(Reuters)
10:01AM
Q3 2023 FibroGen Inc Earnings Call
(Thomson Reuters StreetEvents)
07:00AM
Compugen Reports Third Quarter 2023 Results
(PR Newswire)
Nov-06-23 01:23PM
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
(Zacks)
10:51AM
Pharma Stocks Are Bleeding. But These 2 Look Like Bargains.
(Barrons.com)
10:05AM
Unlocking Q3 Potential of Astrazeneca (AZN): Exploring Wall Street Estimates for Key Metrics
(Zacks)
Nov-05-23 07:08AM
12 Best Large Cap Stocks To Buy Now
(Insider Monkey)
Nov-03-23 11:30AM
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
(Business Wire)
10:06AM
AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data
(FierceBiotech.com)
05:09AM
Q3 2023 Ionis Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents)
Nov-02-23 09:00AM
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
(Zacks)
Nov-01-23 08:02AM
AstraZeneca takes 22% stake in Cellectis as part of collab for 10 cell and gene therapies
(FierceBiotech.com)
07:00AM
Health Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder (NMOSD)
(PR Newswire)
03:00AM
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
(GlobeNewswire)
Oct-31-23 05:50PM
Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know
(Zacks)
Oct-30-23 04:35PM
13 Most Undervalued Pharma Stocks To Buy According To Analysts
(Insider Monkey)
09:30AM
Can Diabetes, Weight-Loss Drugs Get Even Better
(PR Newswire)
09:00AM
Is Trending Stock AstraZeneca PLC (AZN) a Buy Now?
(Zacks)
06:09AM
Merck pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead
(FierceBiotech.com)
05:25AM
11 Best Immunotherapy Stocks To Buy Now
(Insider Monkey)
Oct-28-23 06:50AM
3 No-Brainer Stocks to Buy for Under $100 Right Now
(Motley Fool)
Oct-25-23 05:50PM
Astrazeneca (AZN) Stock Moves -0.56%: What You Should Know
(Zacks)
07:12AM
The ESMO ADC files: After Enhertu success, Daiichi and AstraZeneca branch off for next phase of pipelines
(FierceBiotech.com)
Oct-24-23 09:05PM
PRESS DIGEST-British Business - Oct 25
(Reuters)
12:31PM
AstraZeneca asks the FDA to let adults give themselves the annual flu vaccine
(Yahoo Finance)
10:45AM
ESMO: AstraZeneca aims for '2.0' cancer pipeline, shares bispecific data
(FierceBiotech.com)
08:48AM
Analyst Report: AstraZeneca PLC
(Morningstar Research)
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.